Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- LDP Calls For Acceleration of Medical Devices Review Process
April 14, 2008
- GEDA Inaugurated to Popularize Generic Substitution
April 14, 2008
- TOPICS／Eli Lilly Japan Adds Information on Counterfeit Cialis to Website
April 14, 2008
- All Prescriptions Issued by Some Hospitals Prohibit Use of Generics: NPhA Report
April 14, 2008
- Access to Drugs in Developing Countries Focused on at JPMA Forum
April 14, 2008
- Promotion of Use of Generics Starts on Full Scale
April 14, 2008
- Dr Karasawa Reelected JMA President
April 14, 2008
- Prof. S. Ushimaru Appointed as Successor of Prof. T. Tsuchida at Chuikyo
April 14, 2008
- Family Physicians to Be Trained in Depression Diagnosis and Care
April 14, 2008
- Ethnic Similarities among People in East Asian Countries Focused on at PSJ Symposium
April 14, 2008
- No Increase in Reports of ADRs due to Heparin Products in Japan
April 14, 2008
- Publicity on Lung Age Should Motivate Smokers to Stop
April 14, 2008
- Teijin Licenses Drug for Osteoporosis from Dong Wha Pharm. of South Korea
April 14, 2008
- DSP, Ajinomoto Apply for Combination of Gasmotin and Niflec
April 14, 2008
- TOPICS／7,733 Pass National Exam for Medical Practitioners
April 14, 2008
- STATISTICS／Domestic Drug Production Up 0.7% to \6,438.1 Bil. in 2006
April 14, 2008
- Novel Oral Anticoagulant Pradaxa Approved in EU: Boehringer Ingelheim
April 14, 2008
- Awareness of Peripheral Arterial Disease Low: J&J Survey
April 14, 2008
- Takeda Licenses Prostate Cancer Vaccine from Cell Genesys
April 14, 2008
- Alimta Receives Positive CHMP Opinion for NSCLC First-Line Treatment: Eli Lilly
April 14, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…